We are not just another research and development organization; we are trailblazers in the field, committed to creating groundbreaking solutions for underserved and underrepresented patients worldwide. With a passionate team of experts and state-of-the-art facilities, we embark on a journey of discovery, relentlessly pushing the boundaries of science to develop our own products that can transform lives. Our unwavering dedication to improving patient outcomes is at the heart of everything we do.
We will update this section to provide information on the specific conditions we're conducting clinical trials.
At Rubix LS, our approach to research is centered around the patient. We believe that by putting the patient first, we can develop treatments that are more effective, safer, and more accessible. Our team works closely with patients, caregivers, and advocacy groups to ensure that our research is focused on the needs of the people we serve. We also collaborate with leading academic institutions, hospitals, and biotech companies to stay at the forefront of medical innovation.
RUBIX LS IS FOUNDED
Rubix LS was founded with the mission of conducting research that makes a difference in the lives of patients. From the beginning, we have been committed to putting patients first and developing treatments that meet their needs.
Rubix LS conducts its first clinical trial, testing a new therapy for a rare form of osteonecrotic cancer. The trial results are promising, and the therapy is undergoing continuous studies for approval for use in patients.